The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THYROID-ANDROGEN INTERRELATIONS AND THE HYPOCHOLESTEREMIC EFFECT OF ANDROSTERONE*
HELLMAN, L., Bradlow, H. L., Zumoff, B., Fukushima, D. K., & Gallagher, T. F. (1959) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-19-8-936 · Cited by 154
THE INFLUENCE OF THYROID HORMONE ON HYDROCORTISONE PRODUCTION AND METABOLISM*
HELLMAN, L., Bradlow, H. L., Zumoff, B., & Gallagher, T. F. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-10-1231 · Cited by 128
Cited by
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Lazarow, P. B., & De Duve, C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.6.2043 · Cited by 1,137
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
Reddy, J. K., Lalvvai, N. D., & Farber, E. (1983) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448309029317 · Cited by 879
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 837
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
HESS, R., STÄUBLI, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 594
A historical perspective on the discovery of statins
ENDO, A. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.484 · Cited by 548
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Effects of Anti-inflammatory Drugs on Prostaglandin Biosynthesis
FLOWER, R., GRYGLEWSKI, R., HERBACZŃSKA-CEDRO, K., & VANE, J. R. (1972) · Nature New Biology · doi:10.1038/newbio238104a0 · Cited by 475
Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
Hertz, R., Bishara-Shieban, J., & Bar-Tana, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13470 · Cited by 339
RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB)
Svoboda, D. J., & Azarnoff, D. L. (1966) · The Journal of Cell Biology · doi:10.1083/jcb.30.2.442 · Cited by 265
Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
Miller, D. B., & Spence, J. D. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00003 · Cited by 259
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
BREWER, H. B., ZECH, L. A., GREGG, R. E., SCHWARTZ, D., & SCHAEFER, E. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-623 · Cited by 226
Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
Pirat, C., Farce, A., Lebègue, N., Renault, N., Furman, C., Millet, R., Yous, S., Speca, S., Berthelot, P., Desreumaux, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm101360s · Cited by 198
McCullough, P. A., Ahmed, A. B., Zughaib, M. T., Glanz, E. D., & Loreto, M. J. D. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0619 · Cited by 21
Metadata
- Authors
- THORP, J. M., & WARING, W. S.
- Venue
- Nature
- Published
- 1962-06
- Volume
- 194
- Issue
- 4832
- Pages
- 948-949
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1965553518
- Cited by
- 341
- References
- 2
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.